Divisadero Street Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.39M Buy
+562,153
New +$6.09M 0.27% 57
2025
Q4
Sell
-3,678,125
Closed -$41.1M 98
2025
Q3
$41.1M Buy
3,678,125
+282,695
+8% +$2.73M 1.79% 15
2025
Q2
$33.7M Buy
3,395,430
+2,435,365
+254% +$23.8M 2.15% 12
2025
Q1
$9.02M Buy
960,065
+445,430
+87% +$4.68M 0.91% 32
2024
Q4
$4.71M Buy
+514,635
New +$3.78M 0.55% 40

Other funds holding ANGO

Divisadero Street Capital Management's ANGO Position: Q1 2026 in Review

Divisadero Street Capital Management opened a new position in AngioDynamics (ANGO) in Q1 2026: 562,153 shares worth $6.39M. The stake represents 0.27% of the portfolio and ranks #57 among its holdings. This is a return to the name: Divisadero Street Capital Management previously reported a position in ANGO as recently as Q3 2025.

Divisadero Street Capital Management first reported a position in ANGO in Q4 2024 and has held it in 5 quarters since. The position peaked at $41.1M in Q3 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Divisadero Street Capital Management held 562,153 shares of AngioDynamics worth $6.39M as of Q1 2026.
  • AngioDynamics was a new Divisadero Street Capital Management position in Q1 2026.
  • AngioDynamics made up 0.27% of Divisadero Street Capital Management's portfolio in Q1 2026, its #57 holding.
  • Divisadero Street Capital Management first reported a position in AngioDynamics in Q4 2024 and has held it in 5 quarters since.
  • Divisadero Street Capital Management's AngioDynamics position peaked at $41.1M in Q3 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Divisadero Street Capital Management's 13F filing for Q1 2026, filed 15 May 2026.